Literature DB >> 16943587

Hypothalamic ghrelin treatment modulates NPY-but not CRH-ergic activity in adrenalectomized rats subjected to food restriction: Evidence of a novel hypothalamic ghrelin effect.

Eduardo Spinedi1, Marie-Jeanne Voirol, Chantal Verdumo, Marco Giacominni, François Pralong, Rolf C Gaillard.   

Abstract

It has been proposed that ghrelin induces food intake by a mechanism due to the stimulation of hypothalamic NPY-ergic activity. It is recognized that bilateral adrenalectomy (ADX) enhances hypothalamic CRH-ergic function and reduces appetite. Thus, the aim of the present study was to test whether, icv-administered, ghrelin modulates NPY- and CRH-ergic functions after food restriction (FR) and glucocorticoid deprivation. For this purpose, 1 microg ghrelin was administered icv to ad libitum (AL) eating and to corticosterone (B)-depleted (ADX) and -replete (sham and ADX+B) male animals habituated, for 15 d, to FR. Food intake, hypothalamic function, and peripheral ghrelin, ACTH, and B concentrations were evaluated 2 h after ghrelin administration. Results indicate that while icv ghrelin treatment stimulated 2-h food intake in AL rats, it failed to do so in sham- and ADX+B-FR animals; moreover, 2-h food intake was inhibited by icv ghrelin treatment in ADX-FR rats. Regarding peripheral hormone levels: (a) basal circulating ghrelin levels, already enhanced (vs AL rats) by FR, significantly increased 2 h after icv ghrelin treatment in AL and sham-FR rats; (b) central ghrelin treatment stimulated ACTH secretion in circulation of AL and glucocorticoid-replete-FR rats; and (c) B circulating levels remained unchanged after ghrelin treatment, although they were in relation to the food intake condition of rats. Finally, hypothalamic NPY mRNA expression was enhanced by FR and, in response to icv ghrelin treatment, it decreased in ADX-FR rats only. ADX-enhanced hypothalamic CRH mRNA levels were reduced by ghrelin icv administration only when animals received B replacement therapy. Our data indicate an inhibitory effect of hypothalamic ghrelin on NPY-ergic activity in FR rats lacking endogenous glucocorticoid.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16943587     DOI: 10.1385/ENDO:29:3:477

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  45 in total

1.  Hypothalamic expression of NPY mRNA, vasopressin mRNA and CRF mRNA in response to food restriction and central administration of the orexigenic peptide GHRP-6.

Authors:  Louise E Johnstone; Rungrudee Srisawat; Ekkasit Kumarnsit; Gareth Leng
Journal:  Stress       Date:  2005-03       Impact factor: 3.493

2.  Hypothalamic paraventricular nucleus injections of urocortin alter food intake and respiratory quotient.

Authors:  P J Currie; D V Coscina; C Bishop; C D Coiro; G F Koob; J Rivier; W Vale
Journal:  Brain Res       Date:  2001-10-19       Impact factor: 3.252

3.  Ghrelin induces adiposity in rodents.

Authors:  M Tschöp; D L Smiley; M L Heiman
Journal:  Nature       Date:  2000-10-19       Impact factor: 49.962

4.  Ghrelin strongly stimulates growth hormone release in humans.

Authors:  K Takaya; H Ariyasu; N Kanamoto; H Iwakura; A Yoshimoto; M Harada; K Mori; Y Komatsu; T Usui; A Shimatsu; Y Ogawa; K Hosoda; T Akamizu; M Kojima; K Kangawa; K Nakao
Journal:  J Clin Endocrinol Metab       Date:  2000-12       Impact factor: 5.958

5.  Ghrelin and growth hormone secretagogue receptor are expressed in the rat adrenal cortex: Evidence that ghrelin stimulates the growth, but not the secretory activity of adrenal cells.

Authors:  Paola G Andreis; Ludwik K Malendowicz; Marcin Trejter; Giuliano Neri; Raffaella Spinazzi; Gian Paolo Rossi; Gastone G Nussdorfer
Journal:  FEBS Lett       Date:  2003-02-11       Impact factor: 4.124

6.  Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats.

Authors:  P J Larsen; C Fledelius; L B Knudsen; M Tang-Christensen
Journal:  Diabetes       Date:  2001-11       Impact factor: 9.461

7.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

8.  Molecular determinants of human adipose tissue: differences between visceral and subcutaneous compartments in obese women.

Authors:  V Giusti; M Suter; C Verdumo; R C Gaillard; P Burckhardt; F P Pralong
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

9.  Postprandial response of plasma ghrelin levels to various test meals in relation to food intake, plasma insulin, and glucose.

Authors:  Johannes Erdmann; Robert Töpsch; Florian Lippl; Philipp Gussmann; Volker Schusdziarra
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

10.  Ghrelin is released from rat hypothalamic explants and stimulates corticotrophin-releasing hormone and arginine-vasopressin.

Authors:  A M Mozid; G Tringali; M L Forsling; M S Hendricks; S Ajodha; R Edwards; P Navarra; A B Grossman; M Korbonits
Journal:  Horm Metab Res       Date:  2003-08       Impact factor: 2.936

View more
  1 in total

1.  Acute ghrelin response to intravenous dexamethasone administration in idiopathic short stature or isolated idiopathic growth hormone-deficient children.

Authors:  G Radetti; F Prodam; S Lauriola; G Di Dio; G D'Addato; G Corneli; S Bellone; G Bona
Journal:  J Endocrinol Invest       Date:  2008-03       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.